Rare Hematology Market 2024-2028
Incremental Growth2024-2028 (US$million)
4585.1
2024 Year-over-Year Growth
5.1%
CAGR (2024-2028)
5.7%
Report Coverage
Global
Rare Hematology Segmentation
Market Segmentation & Scope
Market Segment by Geographic Landscape
35.4%
of the growth will originate
from North America
Global Market Size 2018 - 2028 (US$ Million)
Market is segmented by Disease Type into Hemophilia, Sickle cell disease, Thalassemia, Myelodysplastic syndromes
The Hemophilia is expected to be largest growing segment during 2024-2028
Largest Segment - Hemophilia
US$ 19,496.80 Million
Rare Hematology by Disease Type into Hemophilia; 2018-2028 (US$ Million)
Hemophilia Market Revenue and Forecast 2018-2028 (US$ Million)Hemophilia
- Hemophilia Market Size and Forecast 2018 to 2028 (US$ Million)
Rare Hematology by Disease Type into Sickle cell disease; 2018-2028 (US$ Million)
Sickle cell disease Market Revenue and Forecast 2018-2028 (US$ Million)Sickle cell disease
- Sickle cell disease Market Size and Forecast 2018 to 2028 (US$ Million)
Rare Hematology by Disease Type into Thalassemia; 2018-2028 (US$ Million)
Thalassemia Market Revenue and Forecast 2018-2028 (US$ Million)Thalassemia
- Thalassemia Market Size and Forecast 2018 to 2028 (US$ Million)
Rare Hematology by Disease Type into Myelodysplastic syndromes; 2018-2028 (US$ Million)
Myelodysplastic syndromes Market Revenue and Forecast 2018-2028 (US$ Million)Myelodysplastic syndromes
- Myelodysplastic syndromes Market Size and Forecast 2018 to 2028 (US$ Million)
Market is segmented by End-user into Hospitals, Specialty clinics, Research institutes, Pharmaceutical companies
The Hospitals is expected to be largest growing segment during 2024-2028
Largest Segment - Hospitals
US$ 22,963.50 Million
Rare Hematology Size by Segmentation, by End-user (US$ Million)
| End-user | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 4240.30 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Specialty clinics | XX | 3154.60 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Research institutes | XX | XX | 2712.20 | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Pharmaceutical companies | XX | XX | XX | 2193.10 | 2289.90 | XX | XX | XX | XX | XX | XX | XX |
Rare Hematology by End-user into Hospitals; 2018-2028 (US$ Million)
Hospitals Market Revenue and Forecast 2018-2028 (US$ Million)Hospitals
- Hospitals Market Size and Forecast 2018 to 2028 (US$ Million)
Rare Hematology by End-user into Specialty clinics; 2018-2028 (US$ Million)
Specialty clinics Market Revenue and Forecast 2018-2028 (US$ Million)Specialty clinics
- Specialty clinics Market Size and Forecast 2018 to 2028 (US$ Million)
Rare Hematology by End-user into Research institutes; 2018-2028 (US$ Million)
Research institutes Market Revenue and Forecast 2018-2028 (US$ Million)Research institutes
- Research institutes Market Size and Forecast 2018 to 2028 (US$ Million)
Rare Hematology by End-user into Pharmaceutical companies; 2018-2028 (US$ Million)
Pharmaceutical companies Market Revenue and Forecast 2018-2028 (US$ Million)Pharmaceutical companies
- Pharmaceutical companies Market Size and Forecast 2018 to 2028 (US$ Million)
Market is segmented by Geography into North America, Europe, Asia, ROW
The North America is estimated to contribute 35.4% to the growth of global market during the forecast period 2024-2028.
Largest Segment - North America
35.4%
Regional share of different regions, including North America, Europe, Asia, Rest of World (ROW)
| Region | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 4041.60 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Europe | XX | 3985.00 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Asia | XX | XX | 3387.80 | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| ROW | XX | XX | XX | 811.20 | 842.90 | XX | XX | XX | XX | XX | XX | XX |
Rare Hematology Size by Geography into North America; 2018-2028 (US$ Million)
North America Market Revenue and Forecast 2018-2028 (US$ Million)Rare Hematology Size by Country into US; 2018-2028 (US$ Million)
US Market Revenue and Forecast 2018-2028 (US$ Million)Rare Hematology Size by Geography into Europe; 2018-2028 (US$ Million)
Europe Market Revenue and Forecast 2018-2028 (US$ Million)Rare Hematology Size by Country into Germany; 2018-2028 (US$ Million)
Germany Market Revenue and Forecast 2018-2028 (US$ Million)Rare Hematology Size by Country into UK; 2018-2028 (US$ Million)
UK Market Revenue and Forecast 2018-2028 (US$ Million)Rare Hematology Size by Country into France; 2018-2028 (US$ Million)
France Market Revenue and Forecast 2018-2028 (US$ Million)Rare Hematology Size by Country into Italy; 2018-2028 (US$ Million)
Italy Market Revenue and Forecast 2018-2028 (US$ Million)Rare Hematology Size by Geography into Asia; 2018-2028 (US$ Million)
Asia Market Revenue and Forecast 2018-2028 (US$ Million)Rare Hematology Size by Country into China; 2018-2028 (US$ Million)
China Market Revenue and Forecast 2018-2028 (US$ Million)Rare Hematology Size by Country into India; 2018-2028 (US$ Million)
India Market Revenue and Forecast 2018-2028 (US$ Million)Rare Hematology Size by Country into Japan; 2018-2028 (US$ Million)
Japan Market Revenue and Forecast 2018-2028 (US$ Million)Rare Hematology Size by Country into South Korea; 2018-2028 (US$ Million)
South Korea Market Revenue and Forecast 2018-2028 (US$ Million)Rare Hematology Size by Country into Singapore; 2018-2028 (US$ Million)
Singapore Market Revenue and Forecast 2018-2028 (US$ Million)Rare Hematology Size by Geography into ROW; 2018-2028 (US$ Million)
ROW Market Revenue and Forecast 2018-2028 (US$ Million)Major Companies
Market Companies
| Name | Profile | Employees | Headquarters | Website | |
|---|---|---|---|---|---|
| AbbVie Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| AstraZeneca Plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Bayer AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Biogen Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| bluebird bio Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Bristol Myers Squibb Co. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| CSL Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Emmaus Medical Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| F. Hoffmann La Roche Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| GlaxoSmithKline Plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Grifols SA | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Jazz Pharmaceuticals Plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Johnson and Johnson Services Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Merck and Co. Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Novartis AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Novo Nordisk AS | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Octapharma AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Pfizer Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Sanofi SA | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Takeda Pharmaceutical Co. Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com |
Rare Hematology Scope
- By Disease Type
- Introduction / Key Findings
- Historical Market Size Value (US$ million) Analysis By Disease Type, 2018 to 2022
- Current and Future Market Size Value (US$ million) Analysis and Forecast By Disease Type, 2024 to 2028
- Y-o-Y Growth Trend Analysis By Disease Type, 2018 to 2022
- Absolute $ Opportunity Analysis By Disease Type, 2024 to 2028
- By End-user
- Introduction / Key Findings
- Historical Market Size Value (US$ million) Analysis By End-user, 2018 to 2022
- Current and Future Market Size Value (US$ million) Analysis and Forecast By End-user, 2024 to 2028
- Y-o-Y Growth Trend Analysis By End-user, 2018 to 2022
- Absolute $ Opportunity Analysis By End-user, 2024 to 2028
- By Region
- Introduction / Key Findings
- Historical Market Size Value (US$ million) Analysis By Region, 2018 to 2022
- Current and Future Market Size Value (US$ million) Analysis and Forecast By Region, 2024 to 2028
- North America Market Analysis 2018 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ million) Trend Analysis By Market, 2018 to 2022
- Market Size Value (US$ million) Forecast By Market, 2024 to 2028
- By Country
- By Disease Type
- By End-user
- Europe Market Analysis 2018 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ million) Trend Analysis By Market, 2018 to 2022
- Market Size Value (US$ million) Forecast By Market, 2024 to 2028
- By Country
- By Disease Type
- By End-user
- Asia Market Analysis 2018 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ million) Trend Analysis By Market, 2018 to 2022
- Market Size Value (US$ million) Forecast By Market, 2024 to 2028
- By Country
- By Disease Type
- By End-user
- Rest of World (ROW) Market Analysis 2018 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ million) Trend Analysis By Market, 2018 to 2022
- Market Size Value (US$ million) Forecast By Market, 2024 to 2028
- By Disease Type
- By End-user
Major Companies
Market companies
| Name | Profile | Employees | Headquarters | Website | |
|---|---|---|---|---|---|
| AbbVie Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| AstraZeneca Plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Bayer AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Biogen Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| bluebird bio Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Bristol Myers Squibb Co. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| CSL Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Emmaus Medical Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| F. Hoffmann La Roche Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| GlaxoSmithKline Plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Grifols SA | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Jazz Pharmaceuticals Plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Johnson and Johnson Services Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Merck and Co. Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Novartis AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Novo Nordisk AS | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Octapharma AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Pfizer Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Sanofi SA | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Takeda Pharmaceutical Co. Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com |
Subscribe to World-Class Market Intelligence
Basic Plan
Experience the best of reports & insights
